Cardiology CME Center | Cardiology Today

Welcome, Guest

Cardiology Today Home

Upcoming Live Events

Cardiology CME Activities

Show: All Journal Monograph Multimedia


	Glycemic Control and Blood Pressure Control in the Management of Type 2 Diabetes – Podcast Series 6
	Author(s)/Faculty: Jay Shubrook, DO, FACOFP; Suma Dronavalli, MD; William J. Elliott, MD, PhD more Jay Shubrook, DO, FACOFP; Suma Dronavalli, MD; William J. Elliott, MD, PhD
	Source: Cardiology Today	Type: Multimedia	Number of Articles: 3
	Release Date: August 2010	Expiration Date: August 16, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 0.75	Provider:
	OVERVIEW Diabetes and Cardiovascular risk factors


	Optimizing Glycemic Control and Cardiovascular Risk Reduction: A Guidelines-Based Approach – Podcast Series 5
	Author(s)/Faculty: Jeffrey Freeman, DO; Frank Lavernia, MD; Carol H. Wysham, MD more Jeffrey Freeman, DO; Frank Lavernia, MD; Carol H. Wysham, MD
	Source: Cardiology Today	Type: Multimedia	Number of Articles: 3
	Release Date: August 2010	Expiration Date: August 16, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 0.75	Provider:
	OVERVIEW Diabetes and Cardiovascular risk factors


	Minimizing CVD Risk and Complications in the Treatment of Patients with Type 2 Diabetes– Podcast Series 4
	Author(s)/Faculty: Tara Lynn Dall, MD; Steven Jones, MD, FACC, ABCL; Matthew R. Weir, M.D. more Tara Lynn Dall, MD; Steven Jones, MD, FACC, ABCL; Matthew R. Weir, M.D.
	Source: Cardiology Today	Type: Multimedia	Number of Articles: 3
	Release Date: August 2010	Expiration Date: August 16, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 0.75	Provider:
	OVERVIEW Lipid and Diabetes and cardiovascular risks.


	The Role of Incretin-base Therapies in Treating Type 2 Diabetes – Podcast Series 3
	Author(s)/Faculty: George L. Bakris, MD, FAHA, FASN; Mark Stolar, MD; Frank Svec, MD, PhD more George L. Bakris, MD, FAHA, FASN; Mark Stolar, MD; Frank Svec, MD, PhD
	Source: Cardiology Today	Type: Multimedia	Number of Articles: 3
	Release Date: August 2010	Expiration Date: August 16, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 0.50	Provider:
	OVERVIEW Diabetic Kidney Disease


	Recognition, Diagnosis, and Management of Pre-diabetes and New-onset Type 2 Diabetes – Podcast Series 2
	Author(s)/Faculty: Ronald A. Codario, MD, FACP; Anne L. Peters, MD, FACP, CDE; Louis H. Philipson, MD, PhD more Ronald A. Codario, MD, FACP; Anne L. Peters, MD, FACP, CDE; Louis H. Philipson, MD, PhD
	Source: Cardiology Today	Type: Multimedia	Number of Articles: 3
	Release Date: August 2010	Expiration Date: August 16, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 0.75	Provider:
	OVERVIEW Management of Diabetes


	Managing Dyslipidemia, Hypertension, and Cardiovascular Risk Factors in Patients with Diabetes – Podcast Series 1
	Author(s)/Faculty: Michael H. Davidson, MD, FACC, FACP;Tom Dayspring, MD;Matthew Sorrentino, MD, FACC more Michael H. Davidson, MD, FACC, FACP;Tom Dayspring, MD;Matthew Sorrentino, MD, FACC
	Source: Cardiology Today	Type: Multimedia	Number of Articles: 3
	Release Date: August 2010	Expiration Date: August 16, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 0.75	Provider:
	OVERVIEW Managing dyslipidemia and hypertension


	Managing Dysglycemia in Cardiovascular Disease: Preventing Future Events
	Author(s)/Faculty: Michael H. Davidson, MD; Roger S. Blumenthal, MD, FACC, FAHA; Frank Svec, MD, PhD more Michael H. Davidson, MD; Roger S. Blumenthal, MD, FACC, FAHA; Frank Svec, MD, PhD
	Source: CARDIOLOGY TODAY	Type: Multimedia	Number of Articles: 1
	Release Date: April 2010	Expiration Date: April 1, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 1.50	Provider:
	OVERVIEW Dysglycemia is a major risk factor for cardiovascular disease (CVD). Prediabetic states, such as insulin resistance, impaired glucose tolerance, and impaired fasting glucose manifest distinct metabolic abnormalities that contribute to the increased CVD risk. Dyslipidemias are common outcomes of the dysglycemic state, and are often characterized by a high plasma triglyceride (TG) and low high-density lipoprotein cholesterol (HDL-C) concentration. This atherogenic lipoprotein profile is also characterized by relatively smaller and denser low-density lipoprotein cholesterol (LDL-C) particles and enhanced accumulation of remnant lipoproteins, both of which increase cardiovascular risk. In this program, leading clinicians will discuss the importance of achieving and maintaining glycemic control through intensive treatment early in the course of diabetes in order to reduce the incidence of cardiovascular events over time. Other topics that will be discussed include the connection between diabetes and cardiovascular risk factors and the impact of diabetes on triglyicerides, LDL-C and HDL-C. Finally, there will be a discussion of the steps clinicians should take in practice to help patients with diabetes maximize outcomes.

1